Association of the cyclin-dependent kinases and 14-3-3 sigma negatively regulates cell cycle progression
about
Targeted proteomic analysis of 14-3-3 sigma, a p53 effector commonly silenced in cancerNuclear export regulation of COP1 by 14-3-3σ in response to DNA damageCOP9 signalosome subunit 6 stabilizes COP1, which functions as an E3 ubiquitin ligase for 14-3-3σExportin 7 defines a novel general nuclear export pathwayCell Cycle Arrest by a Natural Product via G2/M CheckpointMutation analysis of FANCD2, BRIP1/BACH1, LMO4 and SFN in familial breast cancer.Stratifin (14-3-3 σ) limits plakophilin-3 exchange with the desmosomal plaqueExploration of global gene expression patterns in pancreatic adenocarcinoma using cDNA microarraysEfp targets 14-3-3 sigma for proteolysis and promotes breast tumour growthImmunohistochemical demonstration of 14-3-3 sigma protein in normal human tissues and lung cancers, and the preponderance of its strong expression in epithelial cells of squamous cell lineageThe role of epigenetic inactivation of 14-3-3sigma in human cancerAberrant upregulation of 14-3-3σ and EZH2 expression serves as an inferior prognostic biomarker for hepatocellular carcinomaTumor suppressor ARF inhibits HER-2/neu-mediated oncogenic growthConstitutively active FOXO4 inhibits Akt activity, regulates p27 Kip1 stability, and suppresses HER2-mediated tumorigenicity14-3-3σ Gene Loss Leads to Activation of the Epithelial to Mesenchymal Transition Due to the Stabilization of c-Jun ProteinThe Cytotoxicity Mechanism of 6-Shogaol-Treated HeLa Human Cervical Cancer Cells Revealed by Label-Free Shotgun Proteomics and Bioinformatics AnalysisCombining evidence, biomedical literature and statistical dependence: new insights for functional annotation of gene setsProteomics of breast cancer: outcomes and prospects.Analysis of 14-3-3sigma expression in hyperproliferative skin diseases reveals selective loss associated with CpG-methylation in basal cell carcinoma.Proteomic identification of 14-3-3 sigma as a common component of the androgen receptor and the epidermal growth factor receptor signaling pathways of the human prostate epithelial cell line M12.Serial analysis of gene expression during elongation of the peri-implantation porcine trophectoderm (conceptus).Characterization of a poplar NIMA-related kinase PNek1 and its potential role in meristematic activity.The clinicopathological and prognostic impact of 14-3-3 sigma expression on vulvar squamous cell carcinomas.Down-regulation of 14-3-3 isoforms and annexin A5 proteins in lung adenocarcinoma induced by the tobacco-specific nitrosamine NNK in the A/J mouse revealed by proteomic analysisIdentification of the putative tumor suppressor Nit2 as omega-amidase, an enzyme metabolically linked to glutamine and asparagine transamination.Antineoplastic effects of an Aurora B kinase inhibitor in breast cancer.Role of 14-3-3σ in poor prognosis and in radiation and drug resistance of human pancreatic cancers.Nuclear targeting of cyclin-dependent kinase 2 reveals essential roles of cyclin-dependent kinase 2 localization and cyclin E in vitamin D-mediated growth inhibition.14-3-3σ induces heat shock protein 70 expression in hepatocellular carcinoma.A novel role for 14-3-3sigma in regulating epithelial cell polarity.Vpr protein of human immunodeficiency virus type 1 binds to 14-3-3 proteins and facilitates complex formation with Cdc25C: implications for cell cycle arrestHow do 14-3-3 proteins work?-- Gatekeeper phosphorylation and the molecular anvil hypothesis.DNA replication blockade impairs p53-transactivationEffects of partner proteins on BCA2 RING ligase activity.Apoptosis induced by 1,3,6,7-tetrahydroxyxanthone in Hepatocellular carcinoma and proteomic analysis.P53 mutations in thyroid carcinoma: tidings from an old foe.p53 Dimers associate with a head-to-tail response element to repress cyclin B transcription14-3-3 proteins: key regulators of cell division, signalling and apoptosis.Increasing 14-3-3 sigma expression with declining estrogen receptor alpha and estrogen-responsive finger protein expression defines malignant progression of endometrial carcinoma.14-3-3σ is an independent prognostic biomarker for gastric cancer and is associated with apoptosis and proliferation in gastric cancer.
P2860
Q24298526-5FA33AC4-190C-4FA7-98A9-B50D3B77C1F8Q24299752-5295B5DD-029C-41DA-A722-4D613944302DQ24304964-4FC4E19F-38D8-4869-9E40-2BAD51C66499Q24563375-CEA7DD7D-5954-4529-8232-49E1691483DBQ24810332-E2696E25-D4F6-4ADB-8D10-C90DB71D5095Q25257392-C79F3664-E320-41F1-AB64-6FCC766B5445Q27304412-9C722923-78DF-4496-8A45-3A9C78B29D57Q28185685-F6470453-098E-4ACE-9D29-AF677BEFFB41Q28205889-06586BF8-4898-4964-B33E-CB8A53DCE17FQ28208788-3FF42752-633B-4F46-BD36-6D9071706CB7Q28247253-4B547DB5-498A-4247-B89F-BC9C80EDC04CQ28248070-A6053C9A-EBE9-4B91-BB8A-E0A91C01C73FQ28273757-E6161BF8-4D53-4089-ADD3-72826A7552C1Q28305487-24478C76-81CD-4BF6-B490-011355C7472FQ28385396-1594B16A-3166-4753-B97C-54110B6B8D2BQ28391923-B77F05ED-6B3F-4E98-A3FE-854AC31D2258Q30477452-AF771E56-547A-44CC-882F-E6A304BF9723Q30893442-B268E3F5-A5CC-419B-B9BA-63DD2F23F677Q30977955-C1E06229-A942-4559-8C5E-98A47A470D1AQ33205584-8530E397-448F-4DE3-B465-F8478AA81E54Q33208839-4D9178CD-FBCF-470A-B4F3-BD8C223E3028Q33341471-6B91679D-3BE6-4F0F-9746-991FEB73670CQ33379255-1763FAE1-B313-4451-85CD-6D0368F6AAAFQ33475812-82125810-ED5E-4533-92C5-141748870F7FQ33481441-C79453C9-7881-48F2-BE76-B271F531A6D4Q33732173-9FAAC9E1-EE69-4192-9D6C-07FE0C1194EEQ33735346-6537A07C-C190-46C3-8CD0-7C47B2487738Q33735526-BCDB3CE1-0170-46C2-8CB9-B8453185BA61Q33769256-BB47C11A-9466-4B3E-A61D-A4AE305589FBQ33816790-DF84608C-AE00-4CEA-B7FB-72AB18DCD191Q33834244-9534CDE0-333D-4F7F-AE04-A9995D7C5895Q34120299-0D0893A4-07B3-4A28-B247-838D281BA9B2Q34131340-9D33AA41-E86C-446A-BD92-B8C31DBB3A83Q34153494-24D63C25-096D-4450-BC50-BC4EC54665A6Q34275495-0E3558B4-DD8B-44CF-BE80-D42310545F6CQ34338919-8CCDCE76-3A70-476B-B4D0-69BA49351612Q34384524-F3462920-43A4-4635-85FA-986088ABF981Q34400246-B8EE9F8D-1487-4C99-9FAE-92C9E1730FD8Q34465387-B5073689-A808-4221-B98A-B7048CBAF4B7Q34582807-2BEA3360-F9F1-4889-BB81-304FA8B97BE3
P2860
Association of the cyclin-dependent kinases and 14-3-3 sigma negatively regulates cell cycle progression
description
2000 nî lūn-bûn
@nan
2000 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Association of the cyclin-depe ...... gulates cell cycle progression
@ast
Association of the cyclin-depe ...... gulates cell cycle progression
@en
Association of the cyclin-depe ...... gulates cell cycle progression
@en-gb
Association of the cyclin-depe ...... gulates cell cycle progression
@nl
type
label
Association of the cyclin-depe ...... gulates cell cycle progression
@ast
Association of the cyclin-depe ...... gulates cell cycle progression
@en
Association of the cyclin-depe ...... gulates cell cycle progression
@en-gb
Association of the cyclin-depe ...... gulates cell cycle progression
@nl
prefLabel
Association of the cyclin-depe ...... gulates cell cycle progression
@ast
Association of the cyclin-depe ...... gulates cell cycle progression
@en
Association of the cyclin-depe ...... gulates cell cycle progression
@en-gb
Association of the cyclin-depe ...... gulates cell cycle progression
@nl
P2093
P2860
P921
P356
P1476
Association of the cyclin-depe ...... gulates cell cycle progression
@en
P2093
P2860
P304
23106-23112
P356
10.1074/JBC.M905616199
P407
P577
2000-07-01T00:00:00Z